These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 9681985
1. Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Wang QM, Johnson RB, Sommergruber W, Shepherd TA. Arch Biochem Biophys; 1998 Aug 01; 356(1):12-8. PubMed ID: 9681985 [Abstract] [Full Text] [Related]
2. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates. Wang QM, Sommergruber W, Johnson RB. Biochem Biophys Res Commun; 1997 Jun 27; 235(3):562-6. PubMed ID: 9207196 [Abstract] [Full Text] [Related]
3. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Wang QM, Johnson RB, Cox GA, Villarreal EC, Loncharich RJ. Anal Biochem; 1997 Oct 15; 252(2):238-45. PubMed ID: 9344409 [Abstract] [Full Text] [Related]
4. Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli. Birch GM, Black T, Malcolm SK, Lai MT, Zimmerman RE, Jaskunas SR. Protein Expr Purif; 1995 Oct 15; 6(5):609-18. PubMed ID: 8535153 [Abstract] [Full Text] [Related]
5. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. Kati WM, Sham HL, McCall JO, Montgomery DA, Wang GT, Rosenbrook W, Miesbauer L, Buko A, Norbeck DW. Arch Biochem Biophys; 1999 Feb 15; 362(2):363-75. PubMed ID: 9989947 [Abstract] [Full Text] [Related]
6. Activation of human rhinovirus-14 3C protease. Wang QM, Johnson RB. Virology; 2001 Feb 01; 280(1):80-6. PubMed ID: 11162821 [Abstract] [Full Text] [Related]
7. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. Sommergruber W, Ahorn H, Zöphel A, Maurer-Fogy I, Fessl F, Schnorrenberg G, Liebig HD, Blaas D, Kuechler E, Skern T. J Biol Chem; 1992 Nov 05; 267(31):22639-44. PubMed ID: 1331062 [Abstract] [Full Text] [Related]
8. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. Cordingley MG, Callahan PL, Sardana VV, Garsky VM, Colonno RJ. J Biol Chem; 1990 Jun 05; 265(16):9062-5. PubMed ID: 2160953 [Abstract] [Full Text] [Related]
9. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison. Bjorndahl TC, Andrew LC, Semenchenko V, Wishart DS. Biochemistry; 2007 Nov 13; 46(45):12945-58. PubMed ID: 17944485 [Abstract] [Full Text] [Related]
10. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. Webber SE, Okano K, Little TL, Reich SH, Xin Y, Fuhrman SA, Matthews DA, Love RA, Hendrickson TF, Patick AK, Meador JW, Ferre RA, Brown EL, Ford CE, Binford SL, Worland ST. J Med Chem; 1998 Jul 16; 41(15):2786-805. PubMed ID: 9667969 [Abstract] [Full Text] [Related]
11. Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. Neubauer D, Aumayr M, Gösler I, Skern T. J Gen Virol; 2013 Jul 16; 94(Pt 7):1535-1546. PubMed ID: 23580429 [Abstract] [Full Text] [Related]
12. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. Orr DC, Long AC, Kay J, Dunn BM, Cameron JM. J Gen Virol; 1989 Nov 16; 70 ( Pt 11)():2931-42. PubMed ID: 2555433 [Abstract] [Full Text] [Related]
13. The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. Petersen JF, Cherney MM, Liebig HD, Skern T, Kuechler E, James MN. EMBO J; 1999 Oct 15; 18(20):5463-75. PubMed ID: 10523291 [Abstract] [Full Text] [Related]
14. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase. Davis GJ, Wang QM, Cox GA, Johnson RB, Wakulchik M, Dotson CA, Villarreal EC. Arch Biochem Biophys; 1997 Oct 01; 346(1):125-30. PubMed ID: 9328292 [Abstract] [Full Text] [Related]
15. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Vincents B, von Pawel-Rammingen U, Björck L, Abrahamson M. Biochemistry; 2004 Dec 14; 43(49):15540-9. PubMed ID: 15581366 [Abstract] [Full Text] [Related]
16. Proteolytically active 2A proteinase of human rhinovirus 2 is toxic for Saccharomyces cerevisiae but does not cleave the homologues of eIF-4 gamma in vivo or in vitro. Klump H, Auer H, Liebig HD, Kuechler E, Skern T. Virology; 1996 Jun 01; 220(1):109-18. PubMed ID: 8659103 [Abstract] [Full Text] [Related]
17. Functional determinants of the Epstein-Barr virus protease. Buisson M, Valette E, Hernandez JF, Baudin F, Ebel C, Morand P, Seigneurin JM, Arlaud GJ, Ruigrok RW. J Mol Biol; 2001 Aug 03; 311(1):217-28. PubMed ID: 11469870 [Abstract] [Full Text] [Related]
18. Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. Wang QM, Johnson RB, Cox GA, Villarreal EC, Churgay LM, Hale JE. J Virol; 1998 Feb 03; 72(2):1683-7. PubMed ID: 9445078 [Abstract] [Full Text] [Related]
19. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites. Chanprapaph S, Saparpakorn P, Sangma C, Niyomrattanakit P, Hannongbua S, Angsuthanasombat C, Katzenmeier G. Biochem Biophys Res Commun; 2005 May 20; 330(4):1237-46. PubMed ID: 15823576 [Abstract] [Full Text] [Related]
20. Substrates and inhibitors of human T-cell leukemia virus type I protease. Ding YS, Rich DH, Ikeda RA. Biochemistry; 1998 Dec 15; 37(50):17514-8. PubMed ID: 9860866 [Abstract] [Full Text] [Related] Page: [Next] [New Search]